Stereotactic Body Radiation Therapy With Pembrolizumab in Programmed Cell Death Protein 1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial

International Journal of Radiation Oncology*Biology*Physics 2026 Open access

Read full text
Authors: Jonathan So, Alexander D. Droznin, Payal Tiwari, Yu-Hui Chen, Nicole Grace Chau, Danielle Nina Margalit, Roy B. Tishler, Glenn J. Hanna, R.H. Mak, Kelly J. Fitzgerald, Kartik Sehgal, Shuqiang Li
+12 more Lauren Gunasti, S.E. Kim, Jacqueline Minken, Joanna Baginska, Allison N. Nau, Ilana Gomez Diaz, Bohoon Shim, J. Thomas Janes III, Ravindra Uppaluri, Robert I. Haddad, Kenneth J. Livak, Jonathan Daniel Schoenfeld
DOI: 10.1016/j.ijrobp.2025.12.043
Cited by: 0
References: 27

Fields of Study & Subjects

Head and Neck Cancer Studies Cancer Immunotherapy and Biomarkers Nonmelanoma Skin Cancer Studies

Publication details

Journal / source
International Journal of Radiation Oncology*Biology*Physics
Volume
125
Issue
1
Pages
64–77
Publication date
9 January 2026
Language
EN